What Are Jaw Slimming Injections?
Masseter BTX involves injecting botulinum toxin into the masseter muscles — the large chewing muscles on either side of the jaw. The toxin relaxes the masseter over 4–8 weeks, reducing its bulk and creating a slimmer, more tapered lower face. It is also a medically valid treatment for bruxism (teeth grinding) and TMJ pain.
How Does It Work?
Botulinum toxin blocks acetylcholine release at the neuromuscular junction, causing temporary muscle relaxation. With reduced activity, the masseter gradually atrophies over 4–8 weeks. The result is a slimmer lower jaw angle and a gentler transition from face to neck.
“A jaw slimming injection shrinks a muscle. If the width is fat, skin or bone, it will not change, and a good assessment says so before the first dose.”
Results Timeline
Initial muscle relaxation: 5–7 days. Visible face slimming: 4–8 weeks. Full aesthetic effect — a noticeably slimmer and more defined lower face: 8–12 weeks. Results last 4–6 months initially. With repeat treatment, many patients find the masseter remains smaller for longer and lower maintenance doses are needed.
The V-Shape Combination — Jaw BTX + Chin Filler
A common non-surgical V-shape face combination pairs masseter BTX (jaw angle slimming) with chin projection filler. BTX reduces muscle bulk at the jaw angle over 4–8 weeks; chin filler adds definition at the chin tip — together creating the tapered, balanced V-shaped face profile popular in Singapore. Dr Sin Yong typically plans both in the same session, placing chin filler to complement the anticipated masseter reduction.
Safety Considerations
Common complications from poor technique include asymmetric results, temporary chewing difficulty from over-dosing, and paradoxical jaw widening from incorrect injection point (sublingual space rather than muscle body). Masseter BTX at IN Eternity Clinic is planned by Dr Sin Yong and injected by a doctor, with masseter thickness and symmetry assessed before each treatment. Follow-up at 4 weeks allows correction of early asymmetry if needed.
Ready to Book a Consultation?
Doctor-led care by Dr Sin Yong at 9 Scotts Road, #12-01 Pacific Plaza, Singapore.
WhatsApp +65 8815 3008Frequently Asked Questions
Results typically last 4–6 months. With regular treatment, the masseter gradually reduces and many patients eventually need only once or twice yearly maintenance.
Minimal discomfort. The masseter is a large, accessible muscle. Topical numbing cream is applied. Treatment takes approximately 10–15 minutes.
Over-treatment causing excessive reduction is a known complication. Dr Sin Yong uses conservative initial doses and assesses response at follow-up before recommending top-up. The goal is a naturally slimmer jaw — not a gaunt appearance.
Yes. Both men and women benefit from masseter BTX. Men typically require higher doses due to greater muscle mass. For men, the goal is usually to soften a very square jaw rather than create a V-shape — proportions differ.
The muscle starts to relax within about a week, so chewing may feel slightly weaker. Visible slimming takes longer, usually four to eight weeks, because the muscle shrinks gradually with less use. The full change is judged at around three months.
They can reduce the force of clenching and grinding and the jaw ache that comes with it. They do not treat the cause, so a dentist’s night guard is often still useful, and heavy grinding can shorten how long the slimming lasts.
The muscle gradually regains its strength and bulk over several months, and the lower face returns towards its starting width. Nothing is lost by stopping; the effect simply wears off.
References
- Kim NH, Chung JH, Park RH, Park JB. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005;115(3):919-930. doi:10.1097/01.PRS.0000153236.79775.A0
- Wu WT. Botox facial slimming/facial sculpting: the role of botulinum toxin-A in the treatment of hypertrophic masseteric muscle and parotid enlargement to narrow the lower facial width. Facial Plast Surg Clin North Am 2010;18(1):133-140. doi:10.1016/j.fsc.2009.11.014
- Sundaram H, Signorini M, Liew S, et al. Global Aesthetics Consensus: Botulinum Toxin Type A - Evidence-Based Review, Emerging Concepts, and Consensus Recommendations for Aesthetic Use, Including Updates on Complications. Plast Reconstr Surg 2016;137(3):518e-529e. doi:10.1097/01.prs.0000475758.63709.23
These sources describe mechanisms and general evidence. They are not a promise of any individual result; suitability is decided at an in-person assessment.